Shukra Pharmaceuticals
SHUKRAPHAR · Pharma > Pharmaceuticals & Drugs Listing date: Feb. 23, 2012

Stock Price vs Company Growth
1d
1.9%
1w
2.7%
1m
20.5%
3m
9.6%
6m
171.7%
1y
129.4%
5y
153.0%
10y
44.3%
all
68.8%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec10Jun14Dec17Jun21Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

19.1 1.9%
17.7
27.2
Company Overview

Sales
30.2 Cr
Growth: -33.4%
Profit after Tax
8.18 Cr
Growth: -43.3%
Small Cap
838 Cr
P/E: 96.1x
Industry P/E: 30.5x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 30.2
Growth -33.4%
EBITDA 32.6%
P/S 27.7x
Dividend 1.6%
P/E 96.1x
Book Value ₹ 1.96
PEG Ratio -2.9x
ROE 10.9%
P/B 9.8x
Shareholding Pattern

Institutions
Created with Highcharts 8.2.2Jun22
Promoters
Created with Highcharts 8.2.2Jun22
Others
Created with Highcharts 8.2.2Jun22
Increase    Decrease    No change
Company Profile Detailed

The company is engaged in the business of manufacturing and trading of pharmaceuticals Products, laboratory testing.
Investors (1)
Followers (1)